Shawn Leland's Insider Trades & SAST Disclosures

Shawn Leland's most recent trade in Elevation Oncology Inc was a trade of 186,500 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 14, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Elevation Oncology Inc
Shawn Leland Director, President, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2022 186,500 186,500 - - Employee Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades